Jump to Navigation
Home

Main menu

  • Home
  • News
  • Markets Map
  • Sentiments
  • Topics
  • Data
  • Comments
  • Images
  • Blog
  • About

Secondary menu

  • Latest News
  • Top Rated
  • Most Popular
  • Archive
  • Discussions
  • Microsoft's new Xbox faces wider range of competition
  • Saks Rumors Make No Sense; Neither Does Its Share Price
  • GOLDMAN: 3 Reasons The S&P 500 Is Going To Surge To...
  • OMCs down even as no decision taken on fuel pricing
  • IPL Spot fixing: Sreesanth denies wrongdoing
  • Markets Are On The Verge of Euphoria
  • Rolls-Royce wins engine order from U.S. lessor CIT
  • Osborne braced for IMF verdict on UK economy
  • Search for Oklahoma tornado survivors winds down
  • Capital comments boost Lloyds shares

    FDA Overreach

    Sat, 06/12/2010 - 07:28 EDT - Marginal Revolution
    • Comments
    • Current Affairs
    • Law
    • Medicine

    From the Washington Post:
    The Food and Drug Administration on Friday ordered five companies that offer genome-sequencing tests to consumers, or that provide the scientific services for them, to prove the validity of such products.

    The FDA said the tests, which scan a person's DNA for gene variants associated with specific diseases, are medical devices requiring the agency's approval.

    The ability of genetic tests to predict diseases is currently limited; if the FDA were simply to require firms to acknowledge this point, say with a clear statement of probabilities, that would be one thing (although this task is better met by the FTC under advertising regulation).  But the FDA is brazenly overreaching in trying to regulate genetic tests as medical devices. First, there is no question that these tests are safe--safer than brushing your teeth!--and also effective in identifying genetic markers.  Thus, there is no medical reason whatsoever for regulation.Moreover, genetic tests provide information, personal information about our bodies and our selves.  The FDA has no standing to interfere with the provision of such information.

    Consider, I swab the inside of my cheek and send the sample to a firm. The idea that the FDA can rule on what the firm can and cannot tell me about my own genes is absurd--it's no different than the FDA trying to regulate what my doctor can tell me after a physical examination or what my optometrist can tell me after an eye examination (Please read the first line.  "G T A C C A...").The idea that the FDA can regulate and control what individuals may learn about their own bodies is deeply offensive and, in my view, plainly unconstitutional.

    • Original article
    • Login or register to post comments
     

    Related

    • Does Genetic Medicine Make Economic Sense?

      Genetic scans are getting cheap enough to become a routine part of medical care. But just because they can be doesn’t mean they should be — and the economic case for genetic medicine is far from settled.  

    • Discount DNA

      I'm standing in a balmy room kept warm because the chemicals swishing through dishwasher-size machines on either side of me like it that way. The light is low as small robotic arms inside the devices—they have clear, Plexiglas housings—are moving around samples of DNA, injecting them into flat, microfluidic chips that are a key component of separating out each of the six billion G's, T's, A's, and C's embedded in a human cell. 

    • Can You Really Patent A Gene?

      The question of whether genetic material can or should be patented by pharmaceutical companies is being tested in courts both in the U.S. and overseas.   On Monday, the U.S. Supreme Court heard an appeal by the American Civil Liberties Union and the Public Patent Foundation against Myriad Genetics Inc., a Utah-based private biotechnology company that holds patents on the BRCA1 and BRCA2 genes, two genetic mutations associated with breast and ovarian cancer.  

    • Genetic Screening For Cancer Risk Will Come 'Within Five Years'

      A saliva test to reveal a patient's risk of breast or prostate cancer could be available in doctors' surgeries within five years, according to a "groundbreaking" study. A major research drive involving more than 1,000 experts has revealed more than 80 genes which help determine from birth whether or not someone will develop cancer during their life.

    • Can you know too much about your genes? Jolie has turned a spotlight on testing, but it may have risks

      Ian Willms / Boreal CollectiveJayla Pearce had her genes tested to determine her odds of contracting specific health problems later in her life

    • How Angelina Jolie's Mutant Gene Can Cause Cancer

      Tuesday morning actress and sex symbol Angelina Jolie announced that she had both of her breasts removed in a preventative surgery to reduce her risk for breast cancer.

    • DNA analysis shows that ‘living fossil’ didn’t evolve because it didn’t need to

      The fish known as a living fossil for its close resemblance to ancient predecessors had its genome sequenced by scientists who say it offers clues to how animal ancestors crawled out of the sea. African coelacanth, discovered alive in 1938 after having been presumed extinct for 70 million years, was found to have genes that reveal how land animals’ hands, feet, immune systems and other body features may have evolved, according to a report in the journal Nature.

    • Horsemeat scandal: 'not enough labs in the world' for speedy tests

    • How Much Pain You Can Handle Is Determined By Your Genes

      This article was originally published on Futurity and has been re-printed here under the Creative Commons license.

    • The Fed, Regulation, And The Next Recession

      This op ed appeared in the New York Times yesterday (9/20/2009).

    Latest

    Osborne braced for IMF verdict on UK economy
    Osborne braced for IMF verdict on UK economy
    Club Monaco lights Tumblr lookbook
    Club Monaco lights Tumblr lookbook

    User login

    • Create new account
    • Request new password
    • Click on the icon to sign in with your social network login or enter your Bullfax.com login

    Our Blog

    • Japan’s budget deficit, Rolls-Royce, Raytheon and Sony in Our Daily Round-Up for 05/22/2013
    • Apple chief Tim Cook defends tax practices and denies avoidance
    • Did Iceland make it through the crisis?

    Markets Map

    Markets Map

    Follow Us

    Follow Us on Facebook, Twitter, Google Plus and RSS LinkedIn Facebook Twitter Google Plus RSS
    S&P 500: 1669.16 0.17% FTSE: 6794.95 -0.13% Nikk.: 15627.26 1.58% DAX: 8471.80 -0% HSI: 23261.08 -0.45% FX: EUR/GBP: 1.1671 USD/EUR: 1.2931 JPY/USD: 102.915 Commodities: Gold: 1382.50

    Bullfax.com - Market News & Analysis 2008-2011
    Contact Us | About Us | Terms & Conditions

    Follow Us on Facebook, Twitter, Google Plus and RSS LinkedIn Facebook Twitter Google Plus RSS .

    Secondary menu

    • Latest News
    • Top Rated
    • Most Popular
    • Archive
    • Discussions